Sequenom names Maier interim CFO

Diagnostic company Sequenom Inc. (NASDAQ:SQNM) hired Paul Maier as interim CFO, effective Nov. 10. Maier was SVP and CFO of Ligand Pharmaceuticals Inc. (NASDAQ:LGND) from 1992-2007. Maier replaces Paul Hawran, who resigned last month after an investigation into data related to Sequenom's SEQureDx Down syndrome test (See BioCentury Extra, Monday, Sep. 28, 2009). ...